PATIENTENDREHVORRICHTUNG

Patent europeic · EP4245280 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP4245280
Numer da la dumonda
EP23185261
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-10-2018
Publitgà
20-09-2023
Concedì
04-09-2024
Stritgà
23-05-2025
Motiv
Taxa annuala betg pajada
Classas IPC
A61G 7/00 (2006.01)
A61G 7/057 (2006.01)
Prioritad
GB 201717674 27.10.2017
Derivà da
EP18797076
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-07-2025

    Midada

    Published in Swissreg on 16.07.2025

  2. 23-05-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.05.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.05.2025

  3. 04-09-2024

    Concedì

    Published in Swissreg on 04.09.2024

Partidas

Possessur

Frontier Therapeutics Limited

Newbridge Road Industrial Estate, Blackwood, Gwent NP12 2YN, GB

Inventur

BOSLEY, Simon

Blackwood, NP12 2YN, GB

MORSE, Jonathan

Blackwood, NP12 2YN, GB

WEBBER, Lewys

Blackwood, NP12 2YN, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.